Organon & Co.
OGN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821825
In the last 90 days, Organon & Co. insiders filed 0 open-market purchases and 1 sale; 636 institutions reported holding it in 13F filings for Q2 2026, worth $2.92B in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Organon & Co. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 720 | 6 | 720 | +6 |
| Shares | 198.0M | 866.9K | 199.3M | +2.24M (+1.1%) |
| Value | $2.85B | $12.1M | $3.75B | +$906.3M (+31.9%) |
6 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (86)
Institutions that held Organon & Co. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (80)
Institutions that held Organon & Co. at the end of Q4 2023 and filed for Q1 2024 without it.
Not filed for Q1 2024 yet (6)
Institutions that held Organon & Co. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| M&G Investment Management Ltd | 866,003 | $12.1M |
| Baystate Wealth Management LLC | 427 | $6.17K |
| Bartlett & Co. LLC | 317 | $5.00K |
| Nalls Sherbakoff Group, LLC | 114 | $1.64K |
| Coppell Advisory Solutions LLC | 57 | $822 |
| Strategic Investment Solutions, Inc. | 23 | $336 |